Co-Authors
This is a "connection" page, showing publications co-authored by Yeonjae Kim and Dong-Gyun Lim.
Connection Strength
0.511
-
Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection. Clin Infect Dis. 2019 03 05; 68(6):984-992.
Score: 0.203
-
Sustained Responses of Neutralizing Antibodies Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Recovered Patients and Their Therapeutic Applicability. Clin Infect Dis. 2021 08 02; 73(3):e550-e558.
Score: 0.060
-
Longevity of seropositivity and neutralizing antibodies in recovered MERS patients: a 5-year follow-up study. Clin Microbiol Infect. 2022 Feb; 28(2):292-296.
Score: 0.059
-
Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015. Emerg Infect Dis. 2019 06; 25(6):1161-1168.
Score: 0.052
-
Correlation between Pneumonia Severity and Pulmonary Complications in Middle East Respiratory Syndrome. J Korean Med Sci. 2018 Jun 11; 33(24):e169.
Score: 0.048
-
A Middle East respiratory syndrome screening clinic for health care personnel during the 2015 Middle East respiratory syndrome outbreak in South Korea: A single-center experience. Am J Infect Control. 2018 04; 46(4):436-440.
Score: 0.046
-
Seroprevalence of Middle East Respiratory Syndrome Coronavirus Among Healthcare Personnel Caring for Patients With Middle East Respiratory Syndrome in South Korea. Infect Control Hosp Epidemiol. 2016 12; 37(12):1513-1514.
Score: 0.043